ArticleJournal of the Endocrine Society2025
Methadone Maintenance Treatment, Sex Hormones, and Bone Mineral Density in Persons Who Inject Drugs.
Article in Journal of the Endocrine Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Context: Methadone maintenance treatment (MMT) has been used to treat opioid use disorder, but is associated with bone loss. Sex hormones may mediate this relationship, though studies are limited. Objective: This work aimed to assess the relationships among bone mineral density (BMD) T-score, sex hormones, and MMT among individuals who inject drugs. Methods: We included study participants from the AIDS Linked to the Intravenous Experience (ALIVE) cohort. We performed multivariable linear regression to assess the association of MMT with BMD T-scores (lumbar spine, total hip, and femoral neck) in men and women. We further assessed whether sex hormones estradiol (E2) and free testosterone (free T) influenced the association between MMT and BMD in men and women. We controlled for age, sex, body mass index, smoking and heavy alcohol use (≥3 times per week), HIV status and/or hepatitis C virus viremia, vitamin D level, and heroin use. Results: Among 245 participants (153 men; 92 women), 107 were receiving MMT. Men undergoing MMT were more likely to have a low free T level compared to men not receiving MMT (odds ratio, 3.99; 95% CI, 1.40-11.39; Conclusion: Among men who inject drugs, MMT may contribute to decreased BMD, potentially through decreased levels of free T and total E2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.